Ozempic has no BMI requirement. Unlike weight loss medications that set specific BMI thresholds, Ozempic is FDA-approved exclusively for type 2 diabetes, so the qualifying factor is your blood sugar, not your weight. If you’re searching for a BMI cutoff, you’re likely thinking of Wegovy, which contains the same active ingredient (semaglutide) but is approved specifically for weight management with clear BMI criteria.
Why Ozempic Has No BMI Threshold
The FDA approved Ozempic for three purposes, all related to type 2 diabetes: improving blood sugar control alongside diet and exercise, reducing the risk of major cardiovascular events like heart attack and stroke in people with type 2 diabetes and existing heart disease, and protecting kidney function in people with type 2 diabetes and chronic kidney disease. None of these indications mention body weight or BMI. A person with type 2 diabetes at any weight can be prescribed Ozempic if their doctor determines it’s appropriate for managing their condition.
That said, there’s significant overlap between type 2 diabetes and higher body weight. The American Association of Clinical Endocrinology notes that a BMI of 25 or above, or a history of weight gain, is one of the factors supporting a type 2 diabetes diagnosis. So many people who qualify for Ozempic do carry extra weight, but it’s not a formal requirement.
The BMI Rules That Apply to Wegovy
Wegovy is semaglutide at a higher dose, packaged and approved for long-term weight management rather than diabetes. This is the medication with actual BMI cutoffs. FDA guidelines say weight loss medications like Wegovy can be considered if you meet one of two criteria:
- BMI of 30 or higher (classified as obesity), even without other health conditions
- BMI of 27 or higher with at least one weight-related condition, such as high blood pressure, high cholesterol, or type 2 diabetes
These thresholds are general guidelines rather than hard rules. Some clinicians use clinical judgment to prescribe outside these ranges when they believe a patient will benefit.
Off-Label Prescribing for Weight Loss
Here’s where things get complicated. Many doctors prescribe Ozempic off-label for weight loss in people who don’t have type 2 diabetes. “Off-label” means using an FDA-approved drug for a purpose it wasn’t specifically approved for, which is legal and common in medicine. When this happens, doctors often follow the same BMI guidelines that apply to Wegovy: a BMI of 30 or above, or 27 with a weight-related health problem.
Cleveland Clinic notes that healthcare providers may prescribe semaglutide for people who are overweight (BMI 25 to 29.9) alongside other health conditions, if losing weight would help manage those conditions. In practice, the threshold your doctor uses depends on your full health picture, not just a single number on a BMI chart.
Adjusted Thresholds for Different Ethnicities
Standard BMI cutoffs were developed using data from predominantly white populations, and they don’t capture risk equally across all ethnic backgrounds. People of South Asian, East Asian, Middle Eastern, and Black African or African-Caribbean descent tend to develop metabolic complications at lower BMIs. The 2026 AACE guidelines recommend adjusting thresholds for adults of Asian descent, where a BMI of 23 (rather than 25) indicates overweight and 25 (rather than 30) indicates obesity.
The UK’s National Institute for Health and Care Excellence goes further, recommending that BMI thresholds for semaglutide prescriptions be reduced by 2.5 points for people from these backgrounds. So where the standard cutoff might be 30, someone of South Asian heritage could qualify at 27.5. If you fall into one of these groups, it’s worth knowing that lower thresholds may apply to you.
What Actually Determines Whether You Get a Prescription
In real-world practice, getting prescribed Ozempic or Wegovy depends on more than hitting a BMI number. Your doctor will consider your blood sugar levels and whether you have type 2 diabetes or prediabetes, your cardiovascular risk factors, whether you’ve already tried diet and exercise changes, your kidney function, and your medication history. Insurance coverage adds another layer. Many insurers require a documented type 2 diabetes diagnosis to cover Ozempic and impose their own BMI requirements for Wegovy coverage, sometimes stricter than the FDA guidelines.
If your primary goal is weight loss and you don’t have type 2 diabetes, Wegovy is the version of semaglutide designed and dosed for that purpose. If you have type 2 diabetes and also want to lose weight, Ozempic addresses both, since weight loss is a well-documented effect of the drug even though it’s not the labeled indication. Either way, the conversation with your doctor will focus on your overall metabolic health rather than a single BMI reading.